Skip to content
OpenCapital
Get started

Celestica CLS Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By segment

See full
CCS80%+14.3%
ATS20%-33.3%

Other financials

Income statement

See full
Revenue$4.0B+52.8%
Gross profit$437.2M+59.6%
Operating income$272.1M+111%
Net income$212.3M+146%
EPS (diluted)$1.83+147%

Balance sheet

See full
Cash & equivalents$378.0M+24.8%
Total debt$998.2M-12.3%
Total equity$2.1B+34.8%
Total assets$8.3B+41.6%

Cash flow

See full
Operating cash flow$356.3M+173%
CapEx$229.5M+525%
Free cash flow$126.8M+35.5%

Valuation

See full
Market cap$41.55B+167%
Enterprise value$42.17B+157%
P/E43.4×+6.5×
P/S3×+1.5×

Profitability

See full
Gross margin12%+1.3pp
Operating margin8.6%+2.6pp
Net margin7%+2.8pp
FCF margin3.6%+0.3pp

Returns & leverage

See full
Return on equity52.5%+26.6pp
Debt / equity0.5×-0.3×
Current ratio1.3×-0.2×